Dermatological adverse events during hematological and oncological therapies (Bruton's tyrosine kinase inhibitors and mogamulizumab): an Italian retrospective multicenter study.

Starace M, Cedirian S, Rapparini L, Zengarini C, Gandolfi L, Gualdi G, Lobefaro F, Sollena P, Quaglino P, Ribero S, Merli M, Fulgione E, Vitiello P, Paolino G, Rongioletti F, Calabrese L, D'Onghia M, Cinotti E, Proietti I, Fattore D, Piraccini BM, Pileri A, SIDeMaST Task Force TICURO

Open source

DOI: 10.23736/s2784-8671.25.08294-5
Published: 2025 Oct
Container: Italian journal of dermatology and venereology
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.23736/s2784-8671.25.08294-5,
  title = {Dermatological adverse events during hematological and oncological therapies (Bruton's tyrosine kinase inhibitors and mogamulizumab): an Italian retrospective multicenter study.},
  author = {Starace M and Cedirian S and Rapparini L and Zengarini C and Gandolfi L and Gualdi G and Lobefaro F and Sollena P and Quaglino P and Ribero S and Merli M and Fulgione E and Vitiello P and Paolino G and Rongioletti F and Calabrese L and D'Onghia M and Cinotti E and Proietti I and Fattore D and Piraccini BM and Pileri A and SIDeMaST Task Force TICURO},
  year = {2025},
  journal = {Italian journal of dermatology and venereology},
  doi = {10.23736/s2784-8671.25.08294-5},
  url = {https://doi.org/10.23736/s2784-8671.25.08294-5}
}

RIS

TY  - JOUR
TI  - Dermatological adverse events during hematological and oncological therapies (Bruton's tyrosine kinase inhibitors and mogamulizumab): an Italian retrospective multicenter study.
AU  - Starace M
AU  - Cedirian S
AU  - Rapparini L
AU  - Zengarini C
AU  - Gandolfi L
AU  - Gualdi G
AU  - Lobefaro F
AU  - Sollena P
AU  - Quaglino P
AU  - Ribero S
AU  - Merli M
AU  - Fulgione E
AU  - Vitiello P
AU  - Paolino G
AU  - Rongioletti F
AU  - Calabrese L
AU  - D'Onghia M
AU  - Cinotti E
AU  - Proietti I
AU  - Fattore D
AU  - Piraccini BM
AU  - Pileri A
AU  - SIDeMaST Task Force TICURO
PY  - 2025
JO  - Italian journal of dermatology and venereology
DO  - 10.23736/s2784-8671.25.08294-5
UR  - https://doi.org/10.23736/s2784-8671.25.08294-5
ER  -

APA

M, S., S, C., L, R., C, Z., L, G., G, G., F, L., P, S., P, Q., S, R., M, M., E, F., P, V., G, P., F, R., L, C., M, D., E, C., I, P., D, F., BM, P., A, P., & TICURO, S. T. F. (2025). Dermatological adverse events during hematological and oncological therapies (Bruton's tyrosine kinase inhibitors and mogamulizumab): an Italian retrospective multicenter study.. Italian journal of dermatology and venereology. https://doi.org/10.23736/s2784-8671.25.08294-5

Source records

pubmed · retrieved 2026-09-26T01:25:57.632Z